Aurinia Pharmaceuticals (AUPH) PT Lowered to $6 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Aurinia Pharmaceuticals (AUPH) Tops Q1 EPS by 7c ; Offers Guidance
May 2, 2024 6:01 AM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.07), $0.07 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $48.1 million versus the consensus estimate of $47.07 million.
GUIDANCE:
Aurinia Pharmaceuticals sees FY2024 revenue of $200-220 million, versus the consensus of... More



